Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
02/2013
02/28/2013US20130053395 Pyrazolopyridine kinase inhibitors
02/28/2013US20130053377 Inhibitors of beta-secretase
02/28/2013US20130053375 Amino-quinolines as kinase inhibitors
02/28/2013US20130053363 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE
02/28/2013US20130053362 Heterocyclic compounds and uses thereof
02/28/2013US20130053348 Certain chemical entities, compositions, and methods
02/28/2013US20130048958 Quinacridone derivative, and photoactive layer and photoelectric conversion device including same
02/28/2013DE102011111400A1 Bicyclische heteroaromatische Verbindungen Bicyclic heteroaromatic compounds
02/28/2013CA2846046A1 Bicyclic heteroaromatic compounds
02/28/2013CA2845578A1 Pyrimidine pde10 inhibitors
02/27/2013EP2560973A1 Modulators of 5-ht receptors and methods of use thereof
02/27/2013EP2560972A2 Compounds and methods for kinase modulation, and indications therefor
02/27/2013EP2560971A1 Pyrrolopyridine inhibitors of kinases
02/27/2013EP2560962A1 Indazole compounds useful as ketohexokinase inhibitors
02/27/2013EP2560645A2 Novel conjugates of cc-1065 analogs and bifunctional linkers
02/27/2013CN102947964A Use of substituted perylenes in organic solar cells
02/27/2013CN102947306A 7-(1h-pyrazol-4-yl)-1,6-naphthyridine compounds as SYK inhibitors
02/27/2013CN102947305A Compounds and methods for kinase modulation, and indications therefor
02/27/2013CN102947304A Compounds for electronic devices
02/27/2013CN102947303A Bicyclic pyrimidinyl pyrazoles
02/27/2013CN102947302A Triazolo [4, 5 - b] pyridin derivatives
02/27/2013CN102947301A Quinolizidine and indolizidine derivatives
02/27/2013CN102942581A Spirocyclo-quaternary ammonium salt for supercapacitor and preparation method of spirocyclo-quaternary ammonium salt
02/27/2013CN102942570A 1-trifluoromethyl-2,8-diazospiro[4.5]decane derivative and preparation method thereof
02/27/2013CN102942569A Nicotinic acetylcholine receptorsub-type selective amides of diazabicycloalkanes
02/27/2013CN102942568A 2-[(N- alkyl carbazolyl) vinyl]-1, 8-naphthyridine derivative as well as preparation method and application thereof
02/27/2013CN102942567A Disodium salt crystal of pyrroloquinoline quinone
02/27/2013CN102351859B Antibiotic Pseudonocardian A and Pseudonocardian B, its preparation method thereof and its application in preparation of antibiotics and antitumor drug
02/27/2013CN102153515B N,N'-bis-substituted urea Raf kinase inhibitors and preparation method and application thereof
02/27/2013CN102093367B Preparation method of spiro quaternary ammonium salt for organic electrolyte of super capacitor
02/27/2013CN101959884B Derivatives of 6-heterocyclic-imidazo[l,2-alpha]pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof
02/27/2013CN101553474B Imidazolone and imidazolidinone derivatives as 11b-HSD1 inhibitors for diabetes
02/27/2013CN101389628B Indolopyridines as EG5 kinesin modulators
02/26/2013US8383660 Dibenzyl amine compounds and derivatives
02/26/2013US8383635 Chemical compounds
02/26/2013US8383631 1,6-disubstituted-3-amino-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-C]pyridin-7-one compounds and preparation thereof
02/26/2013CA2523426C Aza spiro alkane derivatives as inhibitors of metalloproteases
02/21/2013WO2013025733A1 Lysophosphatidic acid receptor antagonists
02/21/2013WO2013025628A1 Janus kinase inhibitor compounds and methods
02/21/2013WO2013024731A1 Organic electroluminescent element, compound for organic electroluminescent element, and light-emitting device, display device, and illumination device using said element
02/21/2013WO2013024730A1 Organic electroluminescent element, compound for organic electroluminescent element, and light-emitting device, display device, and illumination device using said element
02/21/2013WO2013024104A1 4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2h-pyran-4-yl)-1 h-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor
02/21/2013WO2013024011A1 Indazole compounds, compositions and methods of use
02/21/2013WO2013024002A1 PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE
02/21/2013WO2012010538A3 Novel processes for the manufacture of propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide
02/21/2013WO2011101069A3 1, 8 -naphthyridines as kinase inhibitors
02/21/2013US20130046097 Substituted heterocycle gamma-carbolines synthesis
02/21/2013US20130046091 Spiro-condensed indoline derivatives as pesticides
02/21/2013US20130045983 Hsp90 inhibitors for therapeutic treatment
02/21/2013US20130045974 Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors
02/21/2013US20130045962 Peptide deformylase inhibitors
02/21/2013CA2844982A1 Lysophosphatidic acid receptor antagonists
02/21/2013CA2843537A1 4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2h-pyran-4-yl)-1 h-imidazo [4,5-c] quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor
02/21/2013CA2843499A1 Indazole compounds, compositions and methods of use
02/21/2013CA2838784A1 Pyrazolo[3,4-c]pyridine compounds and methods of use
02/20/2013EP2559694A2 Azaindoles useful as inhibitors of Janus kinases
02/20/2013EP2559693A1 Polycyclic compound
02/20/2013EP2559687A1 Mesoionic pesticides
02/20/2013EP2559455A1 Heteroaryl derivatives as DGAT1 inhibitors
02/20/2013EP2558465A1 Tricyclic pyridyl-vinyl pyrroles as par1 inhibitors
02/20/2013EP2558464A1 Azacyclic spiroderivatives as hsl inhibitors
02/20/2013EP2558463A1 Fused derivatives as i3 inhibitors
02/20/2013EP2558462A1 Pyridyl-vinyl pyrazoloquinolines as par1 inhibitors
02/20/2013EP2558459A1 Phthalazin-(2h)-one inhibitors of kinases
02/20/2013EP2558449A1 Novel 3,3-dimethyl tetrahydroquinoline derivatives
02/20/2013EP2558446A1 Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
02/20/2013EP2558099A2 Kinase inhibitors
02/20/2013EP2558093A1 Prodrugs of an hiv reverse transcriptase inhibitor
02/20/2013CN102939290A 2,3 dihydro-1h-inden-1-yl- 2,7-diazaspiro [3.6] nonane derivatives and their use as antagonists or inverse agonists of the ghrelin receptor
02/20/2013CN102939289A Substituted 5-fluoro-1h-pyrazolopyridines and use thereof
02/20/2013CN102939284A Agent for treating hcv infection
02/20/2013CN102939283A Indazole compounds useful as ketohexokinase inhibitors
02/20/2013CN102939282A Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
02/20/2013CN102936216A Preparation method of 7,9-dioxo-2,6-aza-spiro[3.5]nona-2-tert-butyl formate and intermediate thereof
02/20/2013CN102358739B Synthetic method for imidazole[1,2-a]pyridine and 2-butyl-5-chloro-1H-imidazole-4-carboxaldehyde compounds
02/20/2013CN102161656B Aspartic acid-specific caspase inhibitors and uses thereof
02/20/2013CN101679427B Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
02/20/2013CN101277700B Pyrimidine compounds as serotonin receptor modulators
02/19/2013US8378108 Apoptosis signal-regulating kinase inhibitors
02/19/2013US8378104 7-aminofuropyridine derivatives
02/19/2013US8378099 Boronic ester and acid compounds, synthesis and uses
02/19/2013US8378098 Imidazol[1,2-α]quinoxalines and derivatives for the treatment of cancers
02/19/2013US8377957 Hydroxy and alkoxy substituted 1H-imidazoquinolines and methods
02/19/2013US8377955 Branched 3- and 6-substituted quinolines as CGRP receptors antagonists
02/19/2013US8377942 Isoxazolines derivatives and their use as pesticide
02/19/2013US8377911 Diuretics
02/19/2013CA2738573C Compositions of propane-1 sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide and uses thereof
02/19/2013CA2486187C Kinase inhibitors
02/19/2013CA2456551C Tumour inhibiting lanthanum compounds
02/14/2013WO2013022814A1 Cyclic p1 linkers as factor xia inhibitors
02/14/2013WO2013022519A1 Pyrido-pyrimidine derivatives
02/14/2013WO2013022047A1 Cyclopropaneamine compound
02/14/2013WO2013021907A1 Organic electric light emitting element, material for said element, and light emitting device, display device, and illumination device employing said element
02/14/2013WO2013021054A1 Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1h-[1,8]naphthyridinones
02/14/2013WO2013021052A1 Antibacterial piperidinyl substituted 3,4-dihydro-1h-[1,8]naphthyridinones
02/14/2013WO2013021051A1 Antibacterial homopiperidinyl substituted 3,4 dihydro 1h [1,8]naphthyridinones
02/14/2013US20130041153 Derivatives having vinyl group and its use in electroluminescent element
02/14/2013US20130041152 6-HETEROCYCLIC IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
02/14/2013US20130041046 Sweet flavor modifier
02/14/2013US20130040984 7-(lH-PYRAZOL-4-YL)-1,6-NAPHTHYRIDINE COMPOUNDS AS SYK INHIBITORS
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 646